Literature DB >> 23881556

Diagnosis and treatment of low-grade osteosarcoma: experience with nine cases.

Katsuhiro Hayashi1, Hiroyuki Tsuchiya, Norio Yamamoto, Toshiharu Shirai, Hideji Nishida, Akihiko Takeuchi, Hiroaki Kimura, Shinji Miwa, Hiroyuki Inatani, Hideki Okamoto, Satoshi Yamada, Hiroko Ikeda, Seiko Sawada-Kitamura, Takayuki Nojima, Akishi Ooi, Takanobu Otsuka.   

Abstract

BACKGROUND: Low-grade osteosarcoma, including low-grade central osteosarcoma and parosteal osteosarcoma, is an extremely rare variant, and the diagnosis is occasionally difficult. In this article we present cases of low-grade osteosarcomas that should be reviewed by a clinical oncologist. PATIENTS AND METHODS: Nine cases of histologically diagnosed Broder grade 1 osteosarcoma were retrospectively reviewed. The pathological diagnoses included parosteal osteosarcoma, low-grade central osteosarcoma, and low-grade chondroblastic osteosarcoma in four, four, and one cases, respectively.
RESULTS: Duration from initial surgical intervention including biopsy to final diagnosis as low-grade osteosarcoma was a mean of 9.4 months. The initial benign diagnoses on biopsy specimens included fibrous dysplasia in three cases, chondroblastoma in one case, and a giant cell tumor in one case. The average number of histological examinations was 1.8. Low-grade osteosarcomas are well suited for biological reconstruction: seven cases were reconstructed by frozen autografts, distraction osteogenesis, or vascularized bone grafts.
CONCLUSION: Low-grade osteosarcomas can be misdiagnosed as benign lesions, especially fibrous dysplasia. If the diagnosis of a low-grade osteosarcoma is not established on the basis of radiologic findings, care should be exercised, even when a biopsy suggests a benign lesion. Low-grade osteosarcomas should be treated with wide excision, even after an intralesional excision. Biological reconstruction might be a better option for low-grade osteosarcomas.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23881556     DOI: 10.1007/s10147-013-0592-z

Source DB:  PubMed          Journal:  Int J Clin Oncol        ISSN: 1341-9625            Impact factor:   3.402


  17 in total

1.  Analysis of SAS gene and CDK4 and MDM2 proteins in low-grade osteosarcoma.

Authors:  P Ragazzini; G Gamberi; M S Benassi; C Orlando; R Sestini; C Ferrari; L Molendini; M R Sollazzo; M Merli; G Magagnoli; F Bertoni; T Bohling; M Pazzagli; P Picci
Journal:  Cancer Detect Prev       Date:  1999

2.  Osteosarcoma around the knee. Intraepiphyseal excision and biological reconstruction with distraction osteogenesis.

Authors:  H Tsuchiya; M E Abdel-Wanis; K Sakurakichi; T Yamashiro; K Tomita
Journal:  J Bone Joint Surg Br       Date:  2002-11

3.  PAROSTEAL OSTEOSARCOMA.

Authors:  J W HARKESS
Journal:  Am Surg       Date:  1964-11       Impact factor: 0.688

4.  Low-grade intraosseous osteosarcoma in northern Japan: advantage of AgNOR and MIB-1 staining in differential diagnosis.

Authors:  K Okada; J Nishida; T Morita; H Kakizaki; A Ishikawa; T Hotta
Journal:  Hum Pathol       Date:  2000-06       Impact factor: 3.466

5.  The hazards of biopsy in patients with malignant primary bone and soft-tissue tumors.

Authors:  H J Mankin; T A Lange; S S Spanier
Journal:  J Bone Joint Surg Am       Date:  1982-10       Impact factor: 5.284

6.  Pedicle frozen autograft reconstruction in malignant bone tumors.

Authors:  Hiroyuki Tsuchiya; Hideji Nishida; Phutsapong Srisawat; Toshiharu Shirai; Katsuhiro Hayashi; Akihiko Takeuchi; Norio Yamamoto; Katsuro Tomita
Journal:  J Orthop Sci       Date:  2010-06-18       Impact factor: 1.601

7.  Outcome of re-excision for intralesionally treated parosteal osteosarcoma.

Authors:  Won Seok Song; Dae-Geun Jeon; Chang-Bae Kong; Wan Hyeong Cho; Soo-Yong Lee
Journal:  J Surg Oncol       Date:  2010-12-22       Impact factor: 3.454

8.  Low grade central osteogenic sarcoma. A long-term followup of 20 patients.

Authors:  P F Choong; D J Pritchard; M G Rock; F H Sim; R A McLeod; K K Unni
Journal:  Clin Orthop Relat Res       Date:  1996-01       Impact factor: 4.176

9.  Effects of liquid nitrogen treatment on the proliferation of osteosarcoma and the biomechanical properties of normal bone.

Authors:  Norio Yamamoto; Hiroyuki Tsuchiya; Katsuro Tomita
Journal:  J Orthop Sci       Date:  2003       Impact factor: 1.601

10.  Intraosseous well-differentiated osteosarcoma.

Authors:  K K Unni; D C Dahlin; R A McLeod; D J Pritchard
Journal:  Cancer       Date:  1977-09       Impact factor: 6.860

View more
  4 in total

1.  [Spindle-cell osteosclerotic bone lesion with MDM2 amplification].

Authors:  C Mogler; M Boxberg; C Knebel; W Weichert; K Wörtler; K Specht
Journal:  Pathologe       Date:  2018-03       Impact factor: 1.011

2.  Low-grade central osteosarcoma in proximal humerus: a rare entity.

Authors:  Fan Tang; Li Min; Yong Zhou; Yi Luo; Chongqi Tu
Journal:  Onco Targets Ther       Date:  2017-10-24       Impact factor: 4.147

3.  Atypical and incomplete pulmonary hypertrophic osteoarthropathy in the left distal femur: a case report.

Authors:  Gang Xu; Norio Yamamoto; Katsuhiro Hayashi; Akihiko Takeuchi; Shinji Miwa; Kentaro Igarashi; Yuta Taniguchi; Yoshihiro Araki; Hirotaka Yonezawa; Sei Morinaga; Hiroyuki Tsuchiya
Journal:  BMC Surg       Date:  2020-11-23       Impact factor: 2.102

4.  Enhanced Antiproliferative Effect of Combined Treatment with Calcitriol and All-Trans Retinoic Acid in Relation to Vitamin D Receptor and Retinoic Acid Receptor α Expression in Osteosarcoma Cell Lines.

Authors:  Silvia Paukovcekova; Dalibor Valik; Jaroslav Sterba; Renata Veselska
Journal:  Int J Mol Sci       Date:  2020-09-09       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.